+1 (619) 956-9114 info@myicfos.com
Follow us

Connect live...

Select the exhibitor's booth below and get connected live.

Click on "Edit" in the right panel to replace this with your own HTML code
About Arise BioPharma

Arise BioPharma
Arise BioPharma
Available from 1:30 PM - 4:00 PM (US/Pacific)
+1 774-232-2865
Indonesia

Arise BioPharma Inc. (Arise) is a wholly owned subsidiary of Peptide Account LLC. Arise holds property rights to several late stage compounds targeting neuro-degenerative illnesses.  It is poised to enter a high-value Phase 2/3 clinical study in an orphan indication, namely Progressive Multifocal Leukocencephalopathy (PML) with prior clinical evidence in a proof of concept Phase 2a study and Emergency INDs.